Bluejay Diagnostics, Inc. (BJDX)
USD 4.17
(-4.79%)
USD 4.17
(-4.79%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|
| Operating Cash Flow | -8.31 Million | -7.74 Million | -4.36 Million | -508.71 Thousand | -1.69 Million |
| Net Income | -9.95 Million | -9.29 Million | -3.48 Million | -1.15 Million | -819.84 Thousand |
| Depreciation & Amortization | 780.95 Thousand | 306.36 Thousand | 145.71 Thousand | 157.03 Thousand | 142.97 Thousand |
| Deferred income taxes | 235.76 Thousand | - | 170.66 Thousand | 42.43 Thousand | -9842.00 |
| Stock-based compensation | 189.24 Thousand | 433 Thousand | 68.45 Thousand | 7370.00 | 14.81 Thousand |
| Change in working capital | 666.72 Thousand | 578.53 Thousand | -1.48 Million | 596.26 Thousand | -178.28 Thousand |
| Other non-cash items | -232.66 Thousand | 237.44 Thousand | 222 Thousand | -153.53 Thousand | -839.94 Thousand |
| Investing Cash Flow | -704.16 Thousand | -1.19 Million | -23.94 Thousand | - | -6021.00 |
| Investments in PPE | -704.16 Thousand | -1.19 Million | -23.94 Thousand | - | -6021.00 |
| Acquisitions | - | - | - | - | - |
| Investment purchases | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - |
| Other Investing Activities | - | - | - | - | - |
| Financing Cash Flow | 1.11 Million | 8075.00 | 22.52 Million | 1.32 Million | 1.51 Million |
| Debt repayment | -4807.00 | -801.00 | -22.49 Million | -270 Thousand | -265 Thousand |
| Dividends payments | - | - | -17.66 Thousand | - | - |
| Common Stock Repurchased | -59.07 Thousand | - | - | - | - |
| Common Stock Issuance | 1.17 Million | 28.87 Thousand | 31.7 Thousand | 1.05 Million | 1.67 Million |
| Other Financing Activities | 1.17 Million | -20 Thousand | 22.52 Million | 540 Thousand | 100 Thousand |
| Accounts receivables | - | - | - | 645.00 | -645.00 |
| Accounts payables | -235.76 Thousand | 298.88 Thousand | -79.15 Thousand | 345.8 Thousand | -25.21 Thousand |
| Inventory | - | - | 84.76 Thousand | 38.74 Thousand | -103.87 Thousand |
| Other working capital | 902.48 Thousand | 279.65 Thousand | -1.49 Million | 211.06 Thousand | -48.54 Thousand |
| Cash at beginning of period | 10.11 Million | 19.04 Million | 912.36 Thousand | 96.01 Thousand | 280.34 Thousand |
| Cash at end of period | 2.2 Million | 10.11 Million | 19.04 Million | 912.36 Thousand | 96.01 Thousand |
| Capital Expenditure | -704.16 Thousand | -1.19 Million | -23.94 Thousand | - | -6021.00 |
| Effect of forex changes on cash | - | - | - | - | - |
| Net cash flow / Change in cash | -7.9 Million | -8.93 Million | 18.13 Million | 816.35 Thousand | -184.33 Thousand |
| Free Cash Flow | -9.01 Million | -8.94 Million | -4.39 Million | -508.71 Thousand | -1.69 Million |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -2.47 Million | -2.32 Million | -2.3 Million | -9.95 Million | -2.29 Million | -2.81 Million |
| Depreciation & Amortization | 53.71 Thousand | 54.32 Thousand | 56.32 Thousand | 780.95 Thousand | 270.78 Thousand | 293.5 Thousand |
| Deferred income taxes | - | - | -351.45 Thousand | 235.76 Thousand | -42.48 Thousand | 29.49 Thousand |
| Stock-based compensation | 6.01 | 11.87 Thousand | -15.56 Thousand | 189.24 Thousand | -42.48 Thousand | 27.7 Thousand |
| Change in working capital | -60.13 Thousand | -34.1 Thousand | -516.79 Thousand | 666.72 Thousand | 944.63 Thousand | 1.01 Million |
| Other non-cash items | 995.12 Thousand | 75.38 Thousand | 352.75 Thousand | -232.66 Thousand | 42.48 Thousand | -27.7 Thousand |
| Investing Cash Flow | -269.99 Thousand | -35.43 Thousand | -87.89 Thousand | -704.16 Thousand | -74.49 Thousand | -201.1 Thousand |
| Investments in PPE | -269.99 Thousand | -35.43 Thousand | -87.89 Thousand | -704.16 Thousand | -74.49 Thousand | -201.1 Thousand |
| Acquisitions | - | - | - | - | - | - |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | - | - | - | - | - | - |
| Financing Cash Flow | 7.25 Million | 3.04 Million | -3050.00 | 1.11 Million | 1.17 Million | -2679.00 |
| Debt repayment | -85.19 Thousand | -4807.00 | -1202.00 | -4807.00 | -1202.00 | -1201.00 |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | 1.00 | -59.07 Thousand | - | -1478.00 |
| Common Stock Issuance | 7.17 Million | 3.05 Million | -1.43 Million | 1.17 Million | 1.17 Million | - |
| Other Financing Activities | -1.13 Million | -711.03 Thousand | -1849.00 | 1.17 Million | 1.17 Million | -1478.00 |
| Accounts receivables | - | - | - | - | - | - |
| Accounts payables | 5577.00 | -219.64 Thousand | -254.36 Thousand | -235.76 Thousand | 448.19 Thousand | -114.81 Thousand |
| Inventory | - | - | - | - | - | - |
| Other working capital | -65.71 Thousand | 185.54 Thousand | -262.42 Thousand | 902.48 Thousand | 496.43 Thousand | 1.12 Million |
| Cash at beginning of period | 2.66 Million | 2.2 Million | 5.07 Million | 10.11 Million | 5.1 Million | 6.78 Million |
| Cash at end of period | 8.05 Million | 2.66 Million | 2.2 Million | 2.2 Million | 5.07 Million | 5.1 Million |
| Capital Expenditure | -269.99 Thousand | -35.43 Thousand | -87.89 Thousand | -704.16 Thousand | -74.49 Thousand | -201.1 Thousand |
| Effect of forex changes on cash | - | - | -1.69 Million | - | -19.01 Thousand | 1.7 Million |
| Net cash flow / Change in cash | 5.39 Million | 452.65 Thousand | -2.86 Million | -7.9 Million | -23.47 Thousand | -1.68 Million |
| Free Cash Flow | -1.85 Million | -2.59 Million | -2.86 Million | -9.01 Million | -1.19 Million | -1.67 Million |
SGP-R
VAS
DITTO-R
SBRE
QBR-B
SFD